| 18 years and more
- | Country :
- France
- | organs :
- Prostate
- Os
- ...
- | Specialty :
- Thérapies Ciblées
Extract
A double-blind, randomised, multiple dose, phase III, multicentre study of alpharadin in the treatment of patients with symptomatic hormone refractory prostate cancer with skeletal metastases.
Scientific Abstract
en cours d'intégration;